ArticleOncotarget2018

FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer.

Abdul Khalid Siraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.